252186-55-3

Upstream product

• 2973-59-3 2-bromoisovanillin 
• 6346-05-0 3-benzyloxy-4-methoxybenzaldehyde 
• 6451-86-1 5-benzyloxy-2-bromo-4-methoxybenzaldehyde 
• 621-59-0 isovanillin 
• 75-52-5 nitromethane 

Downstream Products

• 252186-56-4 1-Bromo-5-methoxy-2-((E)-2-nitro-vinyl)-4-trityloxy-benzene 
• 1026059-54-0 2-(2-bromo-4-methoxy-5-trityloxy-phenyl)-ethylamine 
• 365571-98-8 N-[2-(2-bromo-5-hydroxy-4-methoxyphenyl)-ethyl]-N-[(4-hydroxyphenyl)methyl]-formamide 
• 365571-97-7 4-bromo-5-[N-[(4-hydroxyphenyl)methyl]-2-aminoethyl]-2-methoxyphenol 
• 56522-51-1 2-bromo-5-hydroxy-4-methoxyphenethylamine 

Relevant academic research and scientific papers

Novel derivatives and analogues of galanthamin

New compounds of general formula I 1

Synthesis of (±)-6H-benzofuro[3a,3,2,ef][3]benzazepine: An unnatural analog of (-)-galanthamine

The first total synthesis of an unnatural analog of the anti-Alzheimer drug (-)-galanthamine has been accomplished using K3[Fe(CN)]6 in the key step to build up the heterocyclic ring system via an oxidative tandem cyclization.

First synthesis of neoalangiside, a new tetrahydroisoquinoline- monoterpene glucoside with oxygen functions at unusual C1, C2 positions

The novel structure of neoalangiside, a new tetrahydroisoquinoline- monoterpene glucoside carrying oxygen functions at the unusual C1 and C2 positions, was confirmed by chemical synthesis starting from isovanillin and secologanin.